China Jo-Jo Drugstores In... (CJJD)
China Jo-Jo Drugstores Statistics
Share Statistics
China Jo-Jo Drugstores has 6.54M shares outstanding. The number of shares has increased by -1.65% in one year.
Shares Outstanding | 6.54M |
Shares Change (YoY) | -1.65% |
Shares Change (QoQ) | -1.65% |
Owned by Institutions (%) | 2.4% |
Shares Floating | 3.91M |
Failed to Deliver (FTD) Shares | 284 |
FTD / Avg. Volume | 0.07% |
Short Selling Information
Short Interest | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is null and the forward PE ratio is null.
PE Ratio | null |
Forward PE | n/a |
PS Ratio | 0.03 |
Forward PS | 0.1 |
PB Ratio | 0.3 |
P/FCF Ratio | null |
PEG Ratio | n/a |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for China Jo-Jo Drugstores.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.94, with a Debt / Equity ratio of null.
Current Ratio | 0.94 |
Quick Ratio | 0.71 |
Debt / Equity | null |
Debt / EBITDA | 35.23 |
Debt / FCF | -10.6 |
Interest Coverage | null |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | $164.58K |
Profits Per Employee | $-4.51K |
Employee Count | 939 |
Asset Turnover | 1.63 |
Inventory Turnover | 7.19 |
Taxes
Income Tax | 62.86K |
Effective Tax Rate | -1.51% |
Stock Price Statistics
The stock price has increased by -46.85% in the last 52 weeks. The beta is -0.15, so China Jo-Jo Drugstores's price volatility has been lower than the market average.
Beta | -0.15 |
52-Week Price Change | -46.85% |
50-Day Moving Average | 1.31 |
200-Day Moving Average | 1.84 |
Relative Strength Index (RSI) | 45.42 |
Average Volume (20 Days) | 407.29K |
Income Statement
In the last 12 months, China Jo-Jo Drugstores had revenue of 154.54M and earned -4.23M in profits. Earnings per share was -2.93.
Revenue | 154.54M |
Gross Profit | 31.11M |
Operating Income | -3.53M |
Net Income | -4.23M |
EBITDA | 1.23M |
EBIT | n/a |
Earnings Per Share (EPS) | -2.93 |
Balance Sheet
The company has 20.15M in cash and 43.22M in debt, giving a net cash position of -23.07M.
Cash & Cash Equivalents | 20.15M |
Total Debt | 43.22M |
Net Cash | -23.07M |
Retained Earnings | -73.51M |
Total Assets | 94.19M |
Working Capital | 3.54M |
Cash Flow
In the last 12 months, operating cash flow was -3.16M and capital expenditures -923.64K, giving a free cash flow of -4.08M.
Operating Cash Flow | -3.16M |
Capital Expenditures | -923.64K |
Free Cash Flow | -4.08M |
FCF Per Share | -2.82 |
Margins
Gross margin is 2013000000%, with operating and profit margins of -229000000% and -274000000%.
Gross Margin | 2013000000% |
Operating Margin | -229000000% |
Pretax Margin | -270000000% |
Profit Margin | -274000000% |
EBITDA Margin | 79% |
EBIT Margin | -2.29% |
FCF Margin | -2.64% |
Dividends & Yields
CJJD does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | n/a |
FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for CJJD.
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Stock Splits
The last stock split was on Mar 1, 2024. It was a backward split with a ratio of 1:20.
Last Split Date | Mar 1, 2024 |
Split Type | backward |
Split Ratio | 1:20 |
Scores
Altman Z-Score | 0.37 |
Piotroski F-Score | 2 |